Smell Training for Loss of Smell
(CIPOD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
A research study to assess the baseline olfactory function, mental health status, clinical severity, and immunological profile in patients with smell loss. The impact of a 3-month olfactory training program on smell function, immunological changes, and mental health in patients with smell loss will be evaluated.
The primary purpose of this study is to investigate tissue and blood samples to identify molecules that may be related to smell loss, ultimately aiming to develop future treatments for this condition and correlate with cognition.
Who Is on the Research Team?
Mohamad Chaaban, MD
Principal Investigator
The Cleveland Clinic
Are You a Good Fit for This Trial?
This trial is for people who have lost their sense of smell, including those with nasal or sinus cancer, anomia (trouble naming objects), or sinusitis. Participants should be adults willing to undergo smell training and provide tissue and blood samples.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Smell Training
Trial Overview
The study tests whether a 3-month smell training program can improve the sense of smell, immune response, and mental health in people with olfactory loss. Researchers will also analyze tissue and blood samples to find related molecules.
How Is the Trial Designed?
4
Treatment groups
Active Control
Loss of smell + CRS with nasal polyps (CRSwNP)
Loss of smell + CRS with nasal polyps (CRSwNP) - undergo 3 months of smell training
No loss of smell CRS with nasal polyps (CRSwNP)
No loss of smell / no CRS/no polyps
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cleveland Clinic
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.